Regeneron/Sanofi's Libtayo OK'd in Europe for lung cancer with ≥50% PD-L1 expression
June 25 2021 - 1:45AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart
From Sep 2023 to Sep 2024